Code | 2354D | ||||||||||
MA number | 77/0269/19-S | ||||||||||
Product Form: | cps dur 30x0,5 mg/0,4 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Farmak International Sp. z o.o., Poland | ||||||||||
Therapeutic Class: | 77 - SYMPATHOLYTICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | bottle HDPE | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
Pediatric contraindication: | Yes |
Dokument: | VHS_súhrn_Dutasterid_tamsulozin Xantis.pdf |
Dokument: | VHS_Dutasterid_tamsulozin Xantis.pdf |
SPC: | SPC_Dutasterid_Tamsulozín FMK_cps dur_08_2023.pdf |
PIL: | PIL_Dutasterid_Tamsulozín FMK_cps dur_08_2023.pdf |
Safety feature | Yes |
Data update: | 30.04.2024 |